He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
TABRECTA is the brand of Novartis. Natco believes it is the first company to have filed a substantially-complete ANDA
Natco Pharma intends to defend the matter accordingly
The company will respond to the Warning Letter within the stipulated timelines
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
